4.2 Article

SNP rs2073618 of the Osteoprotegerin Gene Is Associated with Diabetic Retinopathy in Slovenian Patients with Type 2 Diabetes

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Medicine, General & Internal

Osteoprotegerin gene rs2073617 and rs3134069 polymorphisms in type 2 diabetes patients and sex-specific rs2073618 polymorphism as a risk factor for diabetic foot

Piotr Nehring et al.

POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE (2013)

Article Endocrinology & Metabolism

Osteoprotegerin gene polymorphism in diabetic Charcot neuroarthropathy

A. Korzon-Burakowska et al.

DIABETIC MEDICINE (2012)

Article Medicine, Research & Experimental

Does osteoprotegerin relate to micro- and macrovascular complications in long-term type 1 diabetes?

Jakob Grauslund et al.

SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION (2010)

Review Cardiac & Cardiovascular Systems

Osteoprotegerin, vascular calcification and atherosclerosis

Ann Van Campenhout et al.

ATHEROSCLEROSIS (2009)

Article Endocrinology & Metabolism

Acute hyperinsulinemia decreases plasma osteoprotegerin with diminished effect in type 2 diabetes and obesity

Gitte Maria Jorgensen et al.

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2009)

Review Biochemistry & Molecular Biology

Diabetic complications and dysregulated innate immunity

Dana T. Graves et al.

FRONTIERS IN BIOSCIENCE-LANDMARK (2008)

Article Cardiac & Cardiovascular Systems

Osteoprotegerin plasma concentrations correlate with severity of peripheral artery disease

S Ziegler et al.

ATHEROSCLEROSIS (2005)

Article Cardiac & Cardiovascular Systems

Osteoprotegerin is a risk factor for progressive atherosclerosis and cardiovascular disease

S Kiechl et al.

CIRCULATION (2004)

Article Endocrinology & Metabolism

Increased plasma concentrations of osteoprotegerin in type 2 diabetic patients with microvascular complications

ST Knudsen et al.

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2003)

Article Endocrinology & Metabolism

Evaluation of the role of RANK and OPG genes in Paget's disease of bone

W Wuyts et al.

Review Endocrinology & Metabolism

The role of receptor activator of nuclear factor-κB ligand and osteoprotegerin in the pathogenesis and treatment of metabolic bone diseases

LC Hofbauer et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2000)